Helsinki, Finland

Andrei Tauber

USPTO Granted Patents = 3 


Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2003-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Andrei Tauber: Innovator in the Field of Pharmacology

Introduction

Andrei Tauber, based in Helsinki, Finland, is a distinguished inventor with a significant contribution to the field of pharmacology. He holds three patents, focusing on innovative solutions aimed at advancing medical treatment and diagnosis. His work centers on developing compounds that interact with specific receptors, showcasing a blend of creativity and scientific rigor.

Latest Patents

One of Andrei's latest patents involves "Somatostatin receptor 1 and/or 4 selective agonists and antagonists." This invention pertains to (hetero)arylsulfonylamino-based peptidomimetics of a defined formula, which possess high affinity and selectivity for the somatostatin receptor subtypes SSTR1 and SSTR4. These compounds can be employed for the treatment or diagnosis of various diseases or conditions where interaction with these receptors is beneficial. Additionally, he has developed compounds useful for the treatment or prevention of diseases mediated by the alpha-2B-adrenoceptor, marking a significant advancement in medicinal chemistry.

Career Highlights

Throughout his career, Andrei has been associated with notable companies, including Siegfried Wurster and Oy Juvantia Pharma Ltd. His experience in these organizations has allowed him to foster innovation and enhance therapeutic methodologies, contributing to various medical advancements.

Collaborations

Andrei Tauber has collaborated with accomplished colleagues such as Harri Salo and Siegfried Wurster. Together, they have explored groundbreaking ideas and developments in the pharmaceutical sector, illustrating the power of teamwork in advancing health science.

Conclusion

Andrei Tauber stands as a prominent figure in the realm of pharmaceutical innovation. With a focus on developing selective receptor compounds, he continues to pave the way for new treatment possibilities. His substantial patent portfolio not only highlights his inventive spirit but also reinforces the importance of collaboration and innovation in addressing medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…